Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol-/-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine2C receptor agonist

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 3, 2003, Pages 1209-1216

  Damjanoska, K J ^a   Muma, N A ^a   Zhang, Y ^a   D'Souza, D N ^a   Garcia, F ^a   Carrasco, G A ^a   Kindel, G H ^a   Haskins, K A ^a   Shankaran, M ^a   Petersen, B R ^a   Van De Kar, L D ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 2 HYDROXYPROPYL BETA CYCLODEXTRIN; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; CORTICOSTERONE; CORTICOTROPIN; OXYTOCIN; PROLACTIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DOSE RESPONSE; DRUG MECHANISM; HORMONE RELEASE; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; OXYTOCIN BLOOD LEVEL; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT; RECEPTOR UPREGULATION;

AMINOPYRIDINES; ANIMALS; DRUG INTERACTIONS; ETHYLAMINES; FLUOROBENZENES; INDOLES; MALE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TIME FACTORS;

EID: 0037373241     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.043489     Document Type: Article

References (37)

1. Aghajanian GK and Marek GJ (2000) Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Rev 31:302-312.
2. Alper RH (1990) Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat. Neuroendocrinology 51:255-260.
3. Aulakh CS, Hill JL, and Murphy DL (1992) Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats. J Pharmacol Exp Ther 263:588-595.
4. Bagdy G, Szemeredi K, Kanyicska B, and Murphy DL (1989) Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats. J Pharmacol Exp Ther 250:72-78.
5. Barnes NM and Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
6. Ben Jonathan N and Hnasko R (2001) Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22:724-763.
7. Blier P and de Montigny C (1999) Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21:91S-98S.
8. 2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats. Neuropharmacology 31:671-678.
9. 3H]phosphatidylinositols. Naunyn-Schmiedeberg's Arch Pharmacol 365:242-252.
10. 2A receptors. American Society for Pharmacology and Experimental Therapeutics (Great Lakes Chapter), 15th Annual Meeting, Chicago, IL.
11. 2C receptor agonist, RO 60-0175: a pharmacological analysis. Neuropharmacology 38:415-423.
12. Duxon MS, Flanigan TP, Reavley AC, Baxter GS, Blackburn TP, and Fone KCF (1997) Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience 76:323-329.
13. Feldman S and Weidenfeld J (1996) Involvement of amygdalar α adrenoceptors in hypothalamo-pituitary-adrenocortical responses. Neuroreport 7:3055-3057.
14. 2B receptor mRNA in rat brain. Br J Pharmacol 114:369P.
15. 2A receptor mediation of the HPA axis. Neuropharmacology 42:162-169.
16. 2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212. Eur J Pharmacol 311:207-211.
17. 2 agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine. Br J Pharmacol 133:459-466.
18. Jorgensen H, Knigge U, Kjær A, and Warberg J (1999) Adrenocorticotropic hormone secretion in rats induced by stimulation with serotonergic compounds. J Neuroen. docrinol 11:283-290.
19. 2A receptor antagonist MDL 100, 907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacology 15:116-124.,
20. 2C receptor antagonist. Neuropharmacology 36:609-620.
21. 2 receptor activation stimulates ACTH and Ø-endorphin secretion by increasing corticotropin-releasing hormone in the hypophyseal portal blood. Neuroendocrinology 56:851-855.
22. Knigge U, Willems E, Kjær A, Jorgensen H, and Warberg J (1999) Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion. Endocrinology 140:3713-3719.
23. Li Q, Brownfield MS, Battaglia G, Cabrera TM, Levy AD, Rittenhouse PA, and Van de Kar LD (1993) Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2- [1-piperazinyl]-pyrazine (MK-212) and (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCI (DOI). J Pharmacol Exp Ther 200:836-844.
24. 1A receptors. J Pharmacol Exp Ther 282:1581-1590.
25. 2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286:913-924.
26. 2 dopaminergic inhibition of prolactin release in vivo and in vitro. J Pharmacol Exp Ther 257:668-675.
27. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37:953-955.
28. 1 cells. Br J Pharmacol 128:13-20.
29. Richardson Morton KD, Van de Kar LD, Brownfield MS, Lorens SA, Napier TC, and Urban JH (1990) Stress-induced renin and corticosterone secretion is mediated by catecholaminergic nerve terminals in the hypothalamic paraventricular nucleus. Neuroendocrinology 51:320-327.
30. 2A/2C) receptors. J Pharmacol Exp Ther 271:1647-1655.
31. 1C/2 receptors. Endocrinology 133:661-667.
32. 2C, receptor. Psychopharmacology 144:248-254.
33. Steel RGD and Torrie JH (1960) Principles and Procedures of Statistics with Special Reference to the Biological Sciences. McGraw-Hill Book Company, New York.
34. 2A receptors stimulate ACTH, corticosterone, oxytocin, renin and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J Neurosci 21: 3572-3579.
35. 2C receptor agonists. Pharmacol Biochem Behav 69:643-652.
36. Wright DE, Seroogy KB, Lundgren KH, Davis BM, and Jennes L (1995) Comparative localization of serotonin1A, 1C and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 351:357-373.
37. 2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. J Neurosci 22:9635-9642.